Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:626-628
doi: 10.1161/hs0202.103073
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cintas, P.
Right arrow Articles by Larrue, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cintas, P.
Right arrow Articles by Larrue, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
Related Collections
Right arrow Emergency treatment of Stroke
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Thrombolysis

(Stroke. 2002;33:626.)
© 2002 American Heart Association, Inc.


Short Communications

High Rate of Recanalization of Middle Cerebral Artery Occlusion During 2-MHz Transcranial Color-Coded Doppler Continuous Monitoring Without Thrombolytic Drug

Pascal Cintas, MD; Anne Pavy Le Traon, MD, PhD Vincent Larrue, MD

From the Department of Neurology, University of Toulouse (France).

Correspondence to Professor Vincent Larrue, Service de neurologie, Hopital de Rangueil, 1 avenue Jean Poulhes, 31403 Toulouse, France. E-mail larrue.v{at}chu-toulouse.fr

Abstract

Background and Purpose— Experimental evidence indicates that ultrasound can accelerate thrombolysis. We report our findings on early recanalization during transcranial color-coded Doppler (TCCD) continuous monitoring in acute stroke patients with middle cerebral artery (MCA) main stem occlusion.

Methods— We performed continuous TCCD monitorings in 6 consecutive patients with acute MCA main stem occlusion using a 2-MHz transducer. Patients were not treated with recombinant tissue plasminogen activator.

Results— Partial recanalization, defined as blunted waveforms, occurred during monitoring in 5 patients (83%). The mean time to beginning of recanalization was 17.2±9.6 minutes. Complete recanalization at 24 hours occurred in only 1 patient. The mean National Institutes of Health Stroke Scale score in the patients who recanalized during monitoring was 21.2±4.1 at baseline, 19.2±5 at 2 hours, and 15.6±3.4 at 24 hours (P=0.1).

Conclusions— In this short series of patients with acute MCA main stem occlusion, not treated with recombinant tissue plasminogen activator, we found a high rate of early partial recanalization during continuous exposure to 2-MHz ultrasound.


Key Words: middle cerebral artery • thrombolysis • ultrasonography, Doppler, transcranial

Experimental evidence indicates that low-intensity ultrasound, in the range of values used for diagnostic purposes, accelerates thrombolysis by enhancing plasminogen activator-induced fibrinolysis.1,2 Recently, Alexandrov et al3 reported a high rate of recanalization in stroke patients treated with intravenous recombinant tissue plasminogen activator (rtPA) during 1-hour 2-MHz transcranial Doppler (TCD) monitoring, suggesting that ultrasound might have enhanced drug-induced fibrinolysis in these patients. We report our findings on recanalization during 2-MHz transcranial color-coded Doppler (TCCD) continuous monitoring in patients with acute middle cerebral artery (MCA) main stem occlusion who were not treated with rtPA.

Subjects and Methods

This study included consecutive patients admitted to our stroke unit with an acute ischemic stroke who could have a TCCD diagnosis of MCA main stem occlusion within 6 hours from symptom onset. All patients had a brain CT scan before inclusion to evaluate the hyperdense MCA sign. Patients were not treated with intravenous rtPA.

TCCD scannings were performed through the temporal bone window with a 2-MHz transducer (ATL Ultramark 9 HDI). We first used B-mode imaging to visualize the lateral fissure as a hyperechogenic structure, anterior and lateral to the hypoechogenic butterfly-shaped mesencephalic brain stem, in the orbitomeatal plane. A diagnosis of MCA main stem occlusion was made with the use of both color-coded imaging and pulsed-wave Doppler in case of lack of blood flow all along the lateral fissure, with persistent flow in both the ipsilateral anterior cerebral artery and posterior cerebral artery. Then the sample volume (10 mm in length) of the pulsed-wave Doppler was positioned in the initial part of the lateral fissure, where the MCA main stem runs (Figure 1). This allowed us to precisely focus the ultrasound beam on occluded MCAs. In a preliminary study, we found that this method could correctly identify the MCA main stem in 31 of 37 patients (83.8%) without cerebral artery occlusion and had 100% sensitivity compared with color-coded Doppler imaging.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 1. TCD focused on MCA main stem in the lateral fissure, with the use of B-mode imaging. Note the partial recanalization with localized color-coded blood flow and blunted waveforms on Doppler.

The transducer was fixed with a head set, and pulsed-wave ultrasound was continuously delivered on the initial part of the MCA main stem to evaluate possible changes in flow. The spatial-peak temporal average intensity was 415 mW/cm2. The duration of monitoring was 30 minutes in 5 patients and 45 minutes in the remaining patient.

Other TCCD scannings (without monitoring) were performed 2 to 6 hours and 24 hours after the first one to evaluate possible delayed recanalization.

The clinical severity of stroke was evaluated at baseline, 2 hours, and 24 hours with the use of the National Institutes of Health Stroke Scale.

Results

Six patients (5 men and 1 woman; mean age, 54.3±14.7 years) were included. Four patients had a hyperdense MCA sign. All patients received aspirin 250 mg IV as part of their initial treatment.

The mean time from symptom onset to beginning of TCCD monitoring was 210±86 minutes.

Recanalization of the initially occluded MCA main stem occurred during monitoring in 5 patients. Time to beginning of recanalization ranged from 5 to 30 minutes (mean, 17.2±9.6 minutes) after the beginning of monitoring. Peak systolic velocities were reduced and waveforms were blunted (rounded systolic complex) in all cases (Table and Figure 1), suggesting that recanalization was only partial.4


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Recanalization

On the second TCCD scan, performed 2 to 6 hours after the first one, all arteries had recanalized. Peak systolic velocities were reduced and waveforms were blunted in 5 patients, including the patient without recanalization during the monitoring. In the remaining patient, there was a stenotic pattern (focally increased peak systolic velocity and aliasing) of the initially occluded MCA (Table). Evolution of pulsed-wave Doppler in this patient is shown in Figure 2.



View larger version (46K):
[in this window]
[in a new window]
 
Figure 2. Evolution of recanalization in patient 5. a, Initial partial recanalization 12 minutes after beginning of monitoring. b, Increase in peak flow velocity with persistent blunted waveforms 30 seconds later. c, Stenotic flow signal 6 hours later with increased peak systolic velocity up to 300 cm/s.

A third TCCD scan performed 24 hours later in 5 patients showed no further change. The mean National Institutes of Health Stroke Scale score in the 5 patients with recanalization during initial monitoring was 21.2±4.1 at baseline, 19.2±5 at 2 hours, and 15.6±3.4 at 24 hours (P=0.1, ANOVA).

Discussion

In this study of patients with acute MCA main stem occlusion, who were not treated with rtPA and who were scanned within 6 hours of symptom onset, we could document early recanalization in 5 of 6 patients (83%). Recanalization began after a few minutes of continuous exposure to low-intensity ultrasound. In previous studies of early spontaneous recanalization in similar patients not continuously exposed to ultrasound, the rates of recanalization were much lower. Thus, in a recent series of 32 patients with proximal MCA occlusion first seen between 40 minutes and 5.3 hours from the onset of symptoms, only 2 (6.3%) had recanalized on a repeated TCD performed at 6 hours.5 Similarly, in the Duplex Sonography in Acute Stroke (DIAS I) study, among 12 patients with M1 occlusion first scanned within 6 hours of symptom onset, none had recanalized on a control TCCD performed 2 hours after inclusion.6 Finally, in the Prolyse in Acute Cerebral Thromboembolism (PROACT I and PROACT II) studies, which included patients with angiographically proven M1 or M2 occlusion within 6 hours of symptom onset, the recanalization rates at 120 minutes for control patients were 14.3% and 18%, respectively.7,8

Several in vitro studies have established that ultrasound at low intensity enhances enzymatic fibrinolysis, while it has no effect on clot dissolution without plasminogen activator.1,2,9

Recently, in an in vitro model using the same 2-MHz ultrasound system as in the present study, we found that 30-minute insonation of whole blood clots enhanced rtPA-induced thrombolysis by 47% (P=0.01).10 Mechanisms whereby low-intensity ultrasound increases enzymatic fibrinolysis include acoustic microstreaming at clot/blood flow boundary and reversible changes in fibrin structure, which both result in increased plasminogen activator binding to fibrin and transport into the clot.11

In the present study patients were not treated with rtPA. Thus, if we assume that our findings are not coincidental, the high rate of early recanalization and the close temporal relationship between the beginning of continuous exposure to ultrasound and recanalization suggest that low-intensity ultrasound focused on the occluded MCA main stem under control by B-mode imaging may have enhanced endogenous enzymatic fibrinolysis. However, early recanalization was only partial in all patients. Previous work with angiographic correlation suggests that blunted waveforms correspond, at best, to partial deobstruction with delayed filling of distal branches.4 This may explain, at least in part, why the clinical improvement in patients with early recanalization did not reach statistical significance in our study.

The present study has several limitations. The sample size was small, we did not use a control group, and the assessment of MCA patency at the end of monitoring was unblinded. Thus, the findings should be interpreted with caution.

In conclusion, in a short series of consecutive patients with acute MCA main stem occlusion, not treated with rtPA, we found a high rate of early recanalization during continuous exposure to low-intensity, 2-MHz ultrasound. The findings suggest that ultrasound may have played a role in thrombolysis. These findings need to be confirmed in other laboratories before a prospective, controlled study is considered.

Received September 26, 2001; revision received November 8, 2001; accepted November 14, 2001.

References

1. Francis CW, Önundarson PT, Carstensen EL, Blinc A, Meltzer RS, Schwarz K, Marder VJ. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest. 1992; 90: 2063–2068.

2. Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood. 1993; 81: 2636–2643.[Abstract/Free Full Text]

3. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2 MHz transcranial Doppler monitoring. Stroke. 2000; 31: 610–614.[Abstract/Free Full Text]

4. Burgin WS, Malkoff M, Felberg RA, Demchuk AM, Christou I, Grotta JC, Alexandrov AV. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke. 2000; 31: 1128–1132.[Abstract/Free Full Text]

5. Molina C, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, Alvarez-Sabin J. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001; 32: 1079–1084.[Abstract/Free Full Text]

6. Gerriets T, Postert T, Goertler M, Stolz E, Sclachetzki F, Sliwka U, Seidel G, Weber S, Kaps M, for the DIAS (Duplex Sonography in Acute Stroke) Study Group. DIAS I: duplex-sonographic assessment of the cerebrovascular status in acute stroke: a useful tool for future stroke trials. Stroke. 2000; 31: 2342–2345.[Abstract/Free Full Text]

7. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, for the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998; 29: 4–11.[Abstract/Free Full Text]

8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999; 282: 2003–2011.[Abstract/Free Full Text]

9. Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M. Acceleration of thrombolysis through the cranium in a flow model. Ultrasound Med Biol. 2000; 26: 889–895.[CrossRef][Medline] [Order article via Infotrieve]

10. Cintas P, Nguyen F, Pavy le Traon A, Boneu B, Larrue V. Enhancement of rtPA-induced thrombolysis by exposure to low-intensity, high-frequency ultrasound. Cerebrovasc Dis. 2001; 11 (suppl 3): 20.Abstract.

11. Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol. 1995; 21: 419–424.[CrossRef][Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
StrokeHome page
A. V. Alexandrov
Ultrasound Enhancement of Fibrinolysis
Stroke, March 1, 2009; 40(3_suppl_1): S107 - S110.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Eggers, I. R. Konig, B. Koch, G. Handler, and G. Seidel
Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study
Stroke, May 1, 2008; 39(5): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata
Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model
Stroke, March 1, 2008; 39(3): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Sekoranja, J. Loulidi, H. Yilmaz, K. Lovblad, P. Temperli, M. Comelli, and R. F. Sztajzel
Intravenous Versus Combined (Intravenous and Intra-Arterial) Thrombolysis in Acute Ischemic Stroke: A Transcranial Color-Coded Duplex Sonography-Guided Pilot Study
Stroke, July 1, 2006; 37(7): 1805 - 1809.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. Schneider, T. Gerriets, M. Walberer, C. Mueller, R. Rolke, B. M. Eicke, J. Bohl, O. Kempski, M. Kaps, G. Bachmann, et al.
Brain Edema and Intracerebral Necrosis Caused by Transcranial Low-Frequency 20-kHz Ultrasound: A Safety Study in Rats
Stroke, May 1, 2006; 37(5): 1301 - 1306.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Daffertshofer, A. Gass, P. Ringleb, M. Sitzer, U. Sliwka, T. Els, O. Sedlaczek, W. J. Koroshetz, and M. G. Hennerici
Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia: Increased Risk of Hemorrhage With Combined Ultrasound and Tissue Plasminogen Activator: Results of a Phase II Clinical Trial
Stroke, July 1, 2005; 36(7): 1441 - 1446.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Pfaffenberger, B. Devcic-Kuhar, C. Kollmann, S. P. Kastl, C. Kaun, W. S. Speidl, T. W. Weiss, S. Demyanets, R. Ullrich, H. Sochor, et al.
Can a Commercial Diagnostic Ultrasound Device Accelerate Thrombolysis?: An In Vitro Skull Model
Stroke, January 1, 2005; 36(1): 124 - 128.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. V. Alexandrov, C. A. Molina, J. C. Grotta, Z. Garami, S. R. Ford, J. Alvarez-Sabin, J. Montaner, M. Saqqur, A. M. Demchuk, L. A. Moye, et al.
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
N. Engl. J. Med., November 18, 2004; 351(21): 2170 - 2178.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Vemuganti, R. J. Dempsey, and K. K. Bowen
Inhibition of Intercellular Adhesion Molecule-1 Protein Expression by Antisense Oligonucleotides Is Neuroprotective After Transient Middle Cerebral Artery Occlusion in Rat
Stroke, January 1, 2004; 35(1): 179 - 184.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cintas, P.
Right arrow Articles by Larrue, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cintas, P.
Right arrow Articles by Larrue, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
Related Collections
Right arrow Emergency treatment of Stroke
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Thrombolysis